Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 3/20 | 0.46 |
| ▸ | CA6 | P23280 | 3/20 | 0.46 |
| ▸ | CA5A | P35218 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.46 |
| ▸ | CASP2 | P42575 | 2/20 | 0.46 |
| ▸ | F13A1 | P00488 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | THPO | P40225 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amifostine SCHEMBL4709602 | 1.00 | BLM (1.00) | BLMDRD3CA12CA2CA4 | |
| Amifostine SCHEMBL5309668 | 0.98 | BLM (0.96) | BLMDRD3CA12CA2CA4 | |
| Amifostine SCHEMBL4562808 | 0.98 | BLM (0.96) | BLMDRD3CA12CA2CA4 | |
| Amifostine SCHEMBL317195 | 0.98 | BLM (0.96) | BLMDRD3CA12CA2CA4 | |
| Amifostine SCHEMBL1231172 | 0.98 | BLM (0.96) | BLMDRD3CA12CA2CA4 | |
| Amifostine SCHEMBL4732534 | 0.98 | BLM (0.96) | BLMDRD3CA12CA2CA4 | |
| Amifostine SCHEMBL4383022 | 0.98 | BLM (0.96) | BLMDRD3CA12CA2CA4 | |
| Amifostine SCHEMBL20213780 | 0.96 | BLM (0.93) | BLMDRD3CA12CA2CA4 | |
| Amifostine SCHEMBL9614263 | 0.94 | DRD3 (0.89) | BLMDRD3CA12CA2CA4 | |
| SCHEMBL789954 | 0.94 | DRD3 (0.89) | BLMDRD3CA12CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 37353 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| CN-122056884-A | Methods of treating pancreatic cancer | 坎莫森特里克斯公司 | 2026-05-19 | — | — | CN | claimed |
| CN-120899899-B | Gamma delta T cell preparation and preparation method and application thereof | 广州淳泰生物医药科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026102332-A1 | NERVE AND TUMOR HOMING AGENTS AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. (US) | 2026-05-15 | — | — | WO | claimed |
| EP-3978473-B1 | COMPOUND CONTAINING AN INDOLEACETIC ACID CORE STRUCTURE AND USE THEREOF | BEIJING AN JIAN XI BIO MEDICAL TECH CO LTD (CN) | 2026-05-06 | — | — | EP | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260108476-A1 | 2,4 DNP and Prodrugs Thereof for Treatment of Cancer | MITOCHON PHARMACEUTICALS, INC. (US) | 2026-04-23 | — | — | US | claimed |
| EP-4729063-A2 | TREATMENT OF CANCER USING COENZYME Q10 COMBINATION THERAPIES | BPGbio, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| US-12582672-B2 | Vanadium compositions and methods for treatment of cancer | THE BROAD INSTITUTE, INC. (US) | 2026-03-24 | — | — | US | claimed |
| EP-4709378-A1 | COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2026-03-18 | — | — | EP | claimed |
| WO-1994003179-A1 | CRYSTALLINE AMIFOSTINE COMPOSITIONS AND METHODS FOR THE PREPARATION AND USE OF SAME | U.S. BIOSCIENCE, INC. (US) | 1994-02-17 | — | — | WO | claimed |
| EP-0359347-B1 | COVALENTLY-LINKED COMPLEXES AND METHODS FOR ENHANCED CYTOTOXICITY AND IMAGING | NEORX CORPORATION (US) | 1992-12-23 | — | — | EP | claimed |
| US-5167947-A | Enhancement of absorption of radioprotective drugs | SOUTHWEST RESEARCH INSTITUTE (US) | 1992-12-01 | — | — | US | claimed |
| EP-0473673-A1 | METHOD FOR PROTECTION FROM AZT SIDE EFFECTS AND TOXICITY | U.S. BIOSCIENCE (US) | 1992-03-11 | — | — | EP | claimed |
| EP-0409845-A4 | METHOD FOR PROTECTION FROM CHEMOTHERAPEUTIC SIDE EFFECTS | — | 1991-07-03 | — | — | EP | claimed |
| EP-0409845-A1 | METHOD FOR PROTECTION FROM CHEMOTHERAPEUTIC SIDE EFFECTS | U.S. BIOSCIENCE (US) | 1991-01-30 | — | — | EP | claimed |
| WO-1990014007-A1 | METHOD FOR PROTECTION FROM AZT SIDE EFFECTS AND TOXICITY | U.S. BIOSCIENCE (US) | 1990-11-29 | — | — | WO | claimed |
| EP-0359347-A2 | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging | NEORX CORPORATION (US) | 1990-03-21 | — | — | EP | claimed |
| US-4889525-A | WITH AQUEOUS DISPERSION OF OXYGEN CARRYING PERFLUORO COMPOUND AND DISPERSANT | ADAMANTECH, INC. (US) | 1989-12-26 | — | — | US | claimed |
| WO-1989007942-A1 | METHOD FOR PROTECTION FROM CHEMOTHERAPEUTIC SIDE EFFECTS | U.S. BIOSCIENCE (US) | 1989-09-08 | — | — | WO | claimed |